NCT07172399

Brief Summary

blood pressure of diabetic patients will be measured

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 26, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2026

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2026

Expected
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

September 8, 2025

Last Update Submit

September 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • blood pressure

    * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use. * Appropriate cuff size will be used based on mid-arm circumference. * Blood pressure will be measured in the non-dominant arm. * BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position. * The average of the readings will be recorded * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use. * Appropriate cuff size will be used based on mid-arm circumference. * Blood pressure will be measured in the non-dominant arm. * BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position. * The average of the readings will be recorded * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric

    one year

Interventions

blood samples will be taken to discover if there is hyperlipedemia,hyperthrodism or acute kidney injury

All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index ,blood pressure will be measured.

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

cildren from 6 to 18 year old

You may qualify if:

  • Children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year and attending the Pediatric diabetes clinic at Sohag University Hospital will be included as cases.

You may not qualify if:

  • Children and adolescents with T1DM associated with autoimmune hypothyroidism or celiac disease and those who had received any form of corticosteroids therapy for any reason in the last 6 months will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag university hospital

Sohag, Egypt

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood samples

MeSH Terms

Conditions

Hypertension

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
10 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
aya ibrahim

Study Record Dates

First Submitted

September 8, 2025

First Posted

September 15, 2025

Study Start

July 26, 2025

Primary Completion

July 25, 2026

Study Completion (Estimated)

August 5, 2026

Last Updated

September 15, 2025

Record last verified: 2025-09

Locations